Source:http://linkedlifedata.com/resource/pubmed/id/15797994
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-7-4
|
pubmed:abstractText |
After acute infection Epstein-Barr virus (EBV)-specific memory CD8+ T cells exit cell cycle, and a proportion of these antigen-experienced cells re-express CD45RA (CD45 which predominantly express exon A). However, the signals involved are not known. We investigated the roles of interleukin 15 (IL-15) and interferon-alpha/beta (IFN-I) in these processes, since these mediators have a crucial but undefined role in the maintenance of CD8+ T-cell memory. We show that IFN-I (but not IL-15) allows activated EBV-specific CD8+ T cells to leave cell cycle without entering apoptosis. This was associated with up-regulation of the cyclin inhibitor p27, but not of CD45RA. In contrast, IL-15 (but not IFN-I) induced "homeostatic" proliferation and CD45RA re-expression by these cells in vitro. Different signals, therefore, induce quiescence and CD45RA re-expression in activated EBV-specific CD8+ T cells. After T-cell receptor (TCR) activation freshly isolated CD45RA+ antigen-experienced CD8+ T cells show poor proliferative activity but are highly cytotoxic and secrete IFN-gamma efficiently. This suggests functional reprogramming toward effector function but away from proliferation. The induction of quiescence and the generation of proliferation-independent effector CD8+ T cells that re-express CD45RA may minimize the impact of replicative senescence in virus-specific populations that would otherwise occur during decades of persistent infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0006-4971
|
pubmed:author |
pubmed-author:AkbarArne NAN,
pubmed-author:BelaramaniLavinaL,
pubmed-author:DunnePádraic JPJ,
pubmed-author:Fernandez de MattosSilviaS,
pubmed-author:FletcherJean MJM,
pubmed-author:LamEric W-FEW,
pubmed-author:LawrenzMariaM,
pubmed-author:RustinMalcolm H AMH,
pubmed-author:SalmonMikeM,
pubmed-author:SoaresMaria Vieira DMV
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
106
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
558-65
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15797994-Antigens, CD45,
pubmed-meshheading:15797994-CD8-Positive T-Lymphocytes,
pubmed-meshheading:15797994-Case-Control Studies,
pubmed-meshheading:15797994-Cell Cycle,
pubmed-meshheading:15797994-Cytotoxicity, Immunologic,
pubmed-meshheading:15797994-Epstein-Barr Virus Infections,
pubmed-meshheading:15797994-Herpesvirus 4, Human,
pubmed-meshheading:15797994-Humans,
pubmed-meshheading:15797994-Immunologic Memory,
pubmed-meshheading:15797994-Interferon Type I,
pubmed-meshheading:15797994-Interleukin-15,
pubmed-meshheading:15797994-Lymphocyte Activation,
pubmed-meshheading:15797994-Recombinant Proteins
|
pubmed:year |
2005
|
pubmed:articleTitle |
Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific CD8+ T cells during persistent infection.
|
pubmed:affiliation |
Division of Infection and Immunity, 46 Cleveland St, University College London, W1T 4JF United Kingdom.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|